Climate Change Data

Amicus Therapeutics

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Environmental Stewardship
  • Human Capital
  • Governance

Environmental Achievements

  • Identified areas of risk and opportunities in our partner's sustainability programs.
  • Enforced contractual obligations with suppliers to uphold good sustainability practices through their own ESG programs.
  • Engaged employees around good sustainability practices through the GREEN employee resource group (ERG) to further educate on how Amicus and individuals can reduce our carbon footprint.
  • Greater efforts towards reducing our carbon footprint through a reduction in our facilities, increased hybrid working, and occupying office space that is commutable by walking, mass transit, or shared rides.

Social Achievements

  • Increased access to Galafold to more than 2,000 people living with Fabry disease around the world
  • Provided AT-GAA to nearly 200 people living with Pompe disease through our clinical studies and Expanded Access programs
  • Supported a mission-focused culture where employees can contribute to winning teams, feel included, supported, and heard
  • Launched Employee Resource Groups (ERGs) to foster a diverse and inclusive workplace.
  • Certified over 50 trained Mental Health First Aiders globally.

Governance Achievements

  • Reinforced our culture of strong business ethics and sound corporate governance philosophies
  • Continued to integrate sustainability best practices in our operations and with our partners while delivering strong business growth
  • Adopted a Code of Conduct, which applies to all of our officers, directors, and employees
  • Updated charters for our Audit and Compliance Committee, our Compensation and Leadership Development Committee, our Nominating and Corporate Governance Committee, and our Science and Technology Committee.

Climate Goals & Targets

Long-term Goals:
  • Carbon neutrality
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Minimizing environmental footprint as a biotechnology company.
  • Gaining a better understanding of both Amicus' and our partners' GHG emissions and pursuing reduction targets to achieve our aspirational goal of carbon neutrality.
Mitigation Strategies
  • Building out a robust sustainability program.
  • Working towards implementing sustainability objectives into our operations and with our manufacturing and supply partners to achieve a reduction in greenhouse gas (GHG) emissions.
  • Completed an initial review of ESG programs with all direct suppliers.
  • Incorporated environmental and sustainability clauses into supplier contracts.

Supply Chain Management

Supplier Audits: Initial review of ESG programs with all direct suppliers completed in 2022.

Responsible Procurement
  • Incorporating environmental and sustainability clauses into supplier contracts.
  • ESG questionnaire for new suppliers.

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: SASB

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Goal 3 (Good Health and Well-being)
  • Goal 8 (Decent Work and Economic Growth)
  • Goal 12 (Responsible Consumption and Production)
  • Goal 17 (Partnerships for the Goals)

Amicus' initiatives contribute to these goals through its focus on patient care, employee well-being, sustainable business practices, and collaborations with partners.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:0% Scope 1 and 2 GHG emissions

ESG Focus Areas

  • Environmental Stewardship
  • Patients
  • Employees
  • Governance

Environmental Achievements

  • Continued to capture risk and opportunities in our partners’ sustainability programs
  • Implemented contractual obligations with suppliers to maintain good sustainability practices
  • Engaged employees around good sustainability practices
  • Greater efforts towards reducing our carbon footprint

Social Achievements

  • Increasing access to Galafold with over 2,400 people living with Fabry disease around the world
  • Receiving regulatory approvals of our second commercial therapy, Pombiliti™ + Opfolda™, in the United States, European Union, and the United Kingdom
  • Supporting a mission-focused culture where employees can contribute to winning teams, feel included, supported, and heard.
  • Supporting our communities through global charitable giving

Governance Achievements

  • Furthering our culture of strong business ethics and sound corporate governance philosophies
  • Maintaining and fostering our culture of strong business ethics and integrity, and ensuring open lines of communication to encourage employee compliance reporting
  • Continuing partnering with all employees and stakeholders to ensure transparency and proper training on policies, procedures, and best practices
  • Robust risk oversight by senior leadership and the Board of Directors

Climate Goals & Targets

Long-term Goals:
  • carbon neutrality

Environmental Challenges

  • Reducing our carbon footprint as a biotechnology company
  • Quantifying CO2 emissions produced during the supply chain
  • Understanding both Amicus' and our partners' GHG emissions and developing reduction targets to achieve carbon neutrality
Mitigation Strategies
  • Working towards implementing robust sustainability objectives into our operations and with our manufacturing and supply partners to achieve a reduction in greenhouse gas (GHG) emissions
  • Engaging with CDP to gain a better understanding of GHG emissions and create a basis for direct action to improve sustainability
  • Developing sustainability objectives with our manufacturing and supply partners to reduce GHG emissions
  • Implementing contractual obligations with suppliers to maintain good sustainability practices

Supply Chain Management

Responsible Procurement
  • ESG clauses within supplier contracts
  • Annual review of ESG performance across direct suppliers
  • Deep-dive reviews of sustainability programs with key partners

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SASB

UN Sustainable Development Goals

  • Goal 7 (Affordable and Clean Energy)
  • Goal 8 (Decent Work and Economic Growth)
  • Goal 10 (Reduced Inequalities)
  • Goal 3 (Good Health and Well-being)
  • Goal 17 (Partnerships for the Goals)

Amicus aligns its ESG initiatives with several UN Sustainable Development Goals.

Awards & Recognition

  • 2023 Champion of Board Diversity (Forum of Executive Women)